ClinConnect ClinConnect Logo
Search / Trial NCT06598293

Routine Electronic Patient-reported Outcome Measures During and After Radiotherapy: A Randomized Controlled Study

Launched by YONSEI UNIVERSITY · Sep 12, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how using smartphones to report symptoms can help improve the quality of life for cancer patients during and after their radiotherapy treatment. Participants will be asked to share their experiences and any symptoms they have through a simple app on their smartphones while they are receiving treatment and for three months afterward. The information collected will help doctors understand how well patients are doing and may lead to better care based on their feedback.

To participate in this study, you must be at least 18 years old and have a confirmed diagnosis of cancer. It’s important that you are able to use a smartphone to share your symptoms. Unfortunately, if you have terminal cancer or have trouble understanding or using a smartphone, you won't be eligible for this trial. If you join, you can expect regular check-ins about your health and the chance to help improve cancer care for yourself and others.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \> 18
  • Histologically confirmed diagnosis of cancer
  • Eastern Cooperative Oncology Group (ECOG) 0 or 1
  • The ability to own and use a smartphone
  • Exclusion Criteria:
  • Terminal cancer
  • Cognitive impairment
  • Not using your smartphone

About Yonsei University

Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.

Locations

Yongin Si, , Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Hwakyung BYUN, Phd

Principal Investigator

Severance Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported